Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis.

Authors: Lin, Jeffrey H; Huffman, Austin P; Wattenberg, Max M; Walter, David M; Carpenter, Erica L; Feldser, David M; Beatty, Gregory L; Furth, Emma E; Vonderheide, Robert H

Published In J Exp Med, (2020 08 03)

Abstract: Type 1 conventional dendritic cells (cDC1s) are typically thought to be dysregulated secondarily to invasive cancer. Here, we report that cDC1 dysfunction instead develops in the earliest stages of preinvasive pancreatic intraepithelial neoplasia (PanIN) in the KrasLSL-G12D/+ Trp53LSL-R172H/+ Pdx1-Cre-driven (KPC) mouse model of pancreatic cancer. cDC1 dysfunction is systemic and progressive, driven by increased apoptosis, and results in suboptimal up-regulation of T cell-polarizing cytokines during cDC1 maturation. The underlying mechanism is linked to elevated IL-6 concomitant with neoplasia. Neutralization of IL-6 in vivo ameliorates cDC1 apoptosis, rescuing cDC1 abundance in tumor-bearing mice. CD8+ T cell response to vaccination is impaired as a result of cDC1 dysregulation. Yet, combination therapy with CD40 agonist and Flt3 ligand restores cDC1 abundance to normal levels, decreases cDC1 apoptosis, and repairs cDC1 maturation to drive superior control of tumor outgrowth. Our study therefore reveals the unexpectedly early and systemic onset of cDC1 dysregulation during pancreatic carcinogenesis and suggests therapeutically tractable strategies toward cDC1 repair.

PubMed ID: 32453421 Exiting the NIEHS site

MeSH Terms: Aged; Animals; CD8-Positive T-Lymphocytes/immunology; CD8-Positive T-Lymphocytes/pathology; Carcinogenesis/genetics; Carcinogenesis/immunology*; Carcinogenesis/pathology; Dendritic Cells/immunology*; Dendritic Cells/pathology; Female; Humans; Male; Mice; Middle Aged; Neoplasm Proteins/genetics; Neoplasm Proteins/immunology; Neoplasms, Experimental/genetics; Neoplasms, Experimental/immunology*; Neoplasms, Experimental/pathology; Pancreatic Neoplasms/genetics; Pancreatic Neoplasms/immunology*; Pancreatic Neoplasms/pathology

to Top